(Q80116757)
Statements
Dual irreversible kinase inhibitors: quinazoline-based inhibitors incorporating two independent reactive centers with each targeting different cysteine residues in the kinase domains of EGFR and VEGFR-2 (English)
Allan Wissner
Heidi L Fraser
Charles L Ingalls
Russell G Dushin
M Brawner Floyd
Kinwang Cheung
Thomas Nittoli
Malini R Ravi
Xingzhi Tan
Frank Loganzo
23 March 2007